ArticleJournal for immunotherapy of cancer2022

GPC2 antibody-drug conjugate reprograms the neuroblastoma immune milieu to enhance macrophage-driven therapies.

Guillem Pascual-Pasto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.